Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional, Retrospective And Prospective, Multicenter, Single Arm Study Evaluating The Effectiveness And Safety Of Obinutuzumab In Patients With Previously Untreated Advanced Follicular Lymphoma

NCT04034056 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT04034056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04034056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional, Retrospective And Prospective, Multicenter, Single Arm Study Evaluating The Effectiveness And Safety Of Obinutuzumab In Patients With Previously Untreated Advanced Follicular Lymphoma
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
September 2, 2019
Completion date
April 22, 2024
Enrollment
299 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma